Fundraising FoxBios Partners — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
IN8bio is a clinical-stage biopharmaceutical company developing gamma-delta T cell therapies for solid and hematological tumors using its DeltEx platform (allogeneic, autologous, iPSC, and genetically modified approaches).
BiotechHealthtechNew York, US
Lawrence Lamb(Scientific Founder & Chief Scientific Officer)inWilliam Ho(Founder & Chief Executive Officer)inKate Rochlin(Executive Officer)inPatrick McCall(Executive Officer)inTravis Whitfill(Director)inMelissa Beelen(Executive Officer)
Board seatTravis Whitfill· per SEC Form D · $35M raise · filed Sep 2020
410 Medical makes LifeFlow, a hand-operated rapid infuser that lets clinicians quickly deliver blood or fluids to critically ill patients needing volume resuscitation.
HardwareHealthtechMedical DevicesDurham, US
Mark Donald Piehl(Executive Officer, Director)KYLE CHENET(Executive Officer, Director)in
BoardJEFF TERRELL(Director)inSTANLEY D. LYNALL(Director)FRED GOLDWATER(Director)inMAYANK TANEJA(Director)in
Board seatTravis Whitfill· per SEC Form D · $4M raise · filed Aug 2018
Co-investorsBallad VenturesCU Healthcare Innovation FundDuke Capital PartnersOSF VenturesWellstarWolfpack Investor Network+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.